Long-acting Injectable Formulations
Elevating Drug Safety
Maximising Patient Engagement in Clinical Trials
The Emergence of 3D Printing in Expanding Clinical Research and Pharmaceutical Compounding
Two Acts, One Geopolitical Moment
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
How can bioprinting enable better drug discovery?
CEO, Axolotl Biosciences
Dr Stephanie Willerth is a biomedical engineer entrepreneur and thought leader in D bioprinting and neural tissue engineering As CEO of Axolotl Biosciences and a Full Professor at the University of Victoria she leads innovations in personalized medicine through bioink development and human tissue models Her work bridges academia and industry bringing groundbreaking research into realworld healthca...
Articles
APAC’s Biopharma Providers’ Role in Pioneering a Healthcare Revolution
Asias healthcare landscape is undergoing a transformative journey grappling with profound challenges in changing demographics persistent health inequities and the rising burden of increased disease prevalence
Research Insights
Association Between Inflammatory Biomarkers and Cognitive Aging
Systemic inflammation plays a key role in the disease pathology of Alzheimers Disease AD and related dementias Existing literature has examined various inflammatory and cellular immunity biomarkers related to cognitive and brain aging Chronic peripheral inflammation as measured by Creactive protein is associated with an increased risk of dementia including AD dementia and MRIderived biomarkers of brain atrophy among persons with increased genetic susceptibility to AD
Case Studies
External Innovation Implementation Determinants and Performance Measurement: A Case Study from the Pharmaceutical Industry
Abstract With an increasing amount of externally sourced innovations a major success factor for innovationdependent industries such as the pharmaceutical industry is to successfully implement innovations from outside Existing frameworks emphasize creating a strong climate for implementation by developing the learning capabilities of the organization but the
Techno Trends
Protara Therapeutics Introduces Breakthrough TARA-002 for the Treatment of Paediatric Lymphatic Malformations
Protara Therapeutics has introduced TARA for the treatment of paediatric patients with macrocystic and mixed cystic lymphatic malformations LMs a rare congenital disorder
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Viksit Bharat@ 2047 envisioned the Indian Pharma Industry
Professor Md. Faiyazuddin, a distinguished academician with extensive experience working across the government, public and private sectors, sought to leverage his sixteen-year background in pharmacy education, product development, research consultation, and social pharmacy outreach activities in academia and industry. He is a Senior Professor and former Dean, R&D, Al-Karim University, who is lecturing on health and drug delivery research and holds visiting positions at prestigious universities in India and abroad. He has successfully completed research grants from various R&D agencies, such as SERB-DST and foreign agencies (DSR-UoH, DST, UiTM, Malaysia, Sick’s Children Hospital, Canada) worth Rs. 1.12 Million INR. With more than 120 research, conference, and review manuscripts, dozens of books and chapters, 15 accolades and awards, and various IPR have contributed greatly to the pharm fraternity of India. In addition to his daily job, Dr. Faiyazuddin has a keen interest in connecting researchers worldwide for practicing safe drugs under the flagship of the International Pharmaceutical Forum (a community of more than 250 pharma stalwarts across the globe).
Yogesh Subhash Chaudhari, a passionate educator at Dr L H Hiranandani College of Pharmacy, has contributed significantly to this field through research and review of papers in prestigious journals. His insights on AI for Pharmacist Newsletters on Linkedin are as follows.
Advanced Nanobots for ‘Programmed’ Biomedical Applications
Assistant Professor, Department of Applied Sciences, Indian Institute of Information Technology
Research Fellow, Department of Applied Sciences, Indian Institute of Information Technology
3D Printing Revolutionising Nanotechnology
Mansi Athalye is Assistant Professor in Department of Pharmaceutics at L. M. College of Pharmacy, India with approx. 10 years of teaching and research experience. She has published 12 papers in international and national journals and has presented 22 papers in various conferences as author and co-author with 1 Indian Patent granted in 2018.
Sagar Popat is research student pursuing M. Pharmacy in Pharmaceutics at L. M. College of Pharmacy. He has worked on the topic ‘Cataract of goat eye lens by Invitro and Ex-vivo method’. He has published 1 research article and has won 1st prize in oral presentation at national level conference.
Design of Self-antibacterial and Biocompatible Titanium Surfaces for Biomedical Applications
Lalit M Pandey is an Associate Professor at the Department of Biosciences and Bioengineering, IIT Guwahati. His main research interests include biointerfaces and biomaterials, biochemical engineering, and environmental biotechnology. He has published over hundred research articles in international journals and serves on the editorial board of six international journals. He is serving as Associate Editor in Frontiers in Bioengineering and Biotechnology. He has co-edited three books. He is a life member of the International Association of Engineers (IAENG), the National Academy of Sciences (NASI), the Indian Institute of Chemical Engineers (IIChE), the Biotech Research Society, India (BRSI), and Nano and Molecular Society (India) and serves as a reviewer for several peer-reviewed journals.
Accelerating the Medical Writing Process with Automation From research to publication
Nirupama Parate a Senior Associate at Freyr Solutions’ Medicinal Products Division is an MBA Pharmaceutical Tech graduate and has a knack for Medical Writing Automation. She holds experience across pharmaceutical and medical devices ranging from Regulatory Affairs, pharmaceutical marketing and communications, and medical writing automation. She strongly believes in walking the extra mile and adding a personal touch to everything she does.
press releasesRead more...
Chai Discovery Announces Collaboration with Roche in AI-Driven Drug Discovery
Chai Discovery the AI company building a computeraided design suite for proteinbased therapeutics today announced a collaboration with Roche to use Chais AI models and platform in a number of drug discovery programs across its therapeutic areas
PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product
PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed an agreement with Corealis Pharma Inc Corealis a GMPcompliant contract development
HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia
HUTCHMED China Limited announces that the US Food and Drug Administration FDA has granted Orphan Drug Designation to sovleplenib for the treatment of autoimmune hemolytic anemia AIHA Sovleplenib is a novel selective oral spleen tyrosine kinase Syk inhibitor
Abbott and Novo expand partnership to launch Plosbrio® broadening access to semaglutide for advanced diabetes care across Asia Pacific
Abbott the global healthcare leader and Novo a global leader in treatments for serious chronic diseases announced an expanded strategic collaboration to increase access to originator semaglutide for people living with type diabetes across Asia Pacific Under the agreement Abbott will commercialise
Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition
Zuellig Pharma a leading healthcare solutions company in Asia announced the strategic acquisition of a specialized clinical supply facility in Hangzhou China strengthening its clinical sourcing capabilities to better support domestic and international clinical trials
Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S.
Teva Pharmaceutical Industries Ltd and Samsung Bioepis Co Ltd today announced that they have entered into a license and commercialization agreement for two FDAapproved immunology biosimilars infliximababda a biosimilar to Remicade infliximab and ETICOVO etanerceptykro a biosimilar to Enbrel etanerc...
EventsRead more...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
10 - 11
Nov 2026Extractables & Leachables Europe
Parkhotel Schӧnbrunn, Vienna,...
11 - 13
Nov 2026Frontiers in Cancer Science 2026
One Farrer Hotel,1 Farrer Park...
11 - 12
Nov 2026Medical Device Project and Portfolio Management
Chicago, IL, USA
16 - 17
Nov 2026Analytics for Smarter Decisions in Pharma
London, UK
24 - 25
Nov 2026BioPharma Deals - The Survival Series
Munich, Germany
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
26 - 28
Nov 2026One Health Conference 2026
Thapar Institute of Engineerin...
LATEST NEWSRead more...
Johnson & Johnson Receives Approval for RYBREVANT FASPRO to Treat Advanced Head and Neck Cancer
Johnson Johnson has received accelerated approval from the US Food and Drug Administration FDA for RYBREVANT FASPRO amivantamab and hyaluronidaselpuj to treat adults with recurrent or metastatic head and neck squamous cell carcinoma HNSCC
Boehringer Ingelheim Enters into Partnership with SBP Group to Advance Next-Generation Cancer Therapies
Boehringer Ingelheim and Sino Biopharmaceutical SBP Group have entered into a multiprogram partnership to develop potential nextgeneration cancer treatments using antibodydrug conjugate ADC and Tcell engager TcE technologies
MindWalk Partners with Teva to Support Antibody Discovery Using AI
MindWalk has entered into a multiyear agreement with Teva Pharmaceuticals Australia to support antibody discovery and design optimisation using AI technology ReefIQ is MindWalks biological context platform for the life sciences sector powered by its HYFT technology The technology
CStone Enters into Collaboration with Kimia Therapeutics to Advance Clinical Development of Novel Oncology Drug
CStone Pharmaceuticals has entered into a clinical development collaboration with USbased Kimia Therapeutics to advance a potential firstinclass drug candidate targeting the DNA damage response DDR pathway which plays an important role in the survival of solid tumour cells
DKSH and The Baker Company Partner to Expand Cell Culture and Microbiology Research
DKSH Business Unit Technology has entered into an exclusive distribution agreement with The Baker Company to make its Baker Ruskinn range of controlledenvironment technologies available to laboratories across Thailand The partnership aims to improve access to equipment used in cell culture tissue c...
Fresenius Enters into Agreement with WuXi Biologics to Expand Biosimilars Pipeline
Fresenius has entered into an exclusive development agreement with WuXi Biologics to expand its biosimilars pipeline and strengthen its biopharmaceutical business The partnership will give Fresenius access to WuXi Biologics capabilities in biologics research development and manufacturing
